Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28443543 | 0.98 | NOS2 (0.33) | NOS2CNR2ALDH1A1TSHRCNR1 | |
| SCHEMBL28452832 | 0.93 | CNR2 (0.36) | NOS2CNR2ALDH1A1TSHRCNR1 | |
| Bromide SCHEMBL29193927 | 0.91 | CNR2 (0.35) | NOS2CNR2CNR1HTT | |
| SCHEMBL2282469 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TSHRTPMT | |
| SCHEMBL2228016 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TSHRTPMT | |
| SCHEMBL6249871 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TSHRTPMTMAPT | |
| SCHEMBL2291663 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TSHRTPMTMAPT | |
| SCHEMBL21409639 | 0.85 | ALDH1A1 (0.35) | NOS2ALDH1A1TSHR | |
| SCHEMBL6250251 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TSHRTPMTMAPT | |
| Hydrochloric Acid SCHEMBL29193780 | 0.83 | ALDH1A1 (0.33) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016076437-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2016-05-19 | — | — | WO | disclosed |
| US-8791305-B2 | Ligands and catalyst systems for hydroformylation processes | UMICORE AG & CO. KG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20140114090-A1 | LIGANDS AND CATALYST SYSTEMS FOR HYDROFORMYLATION PROCESSES | UMICORE AG & CO. KG (DE) | 2014-04-24 | — | — | US | disclosed |
| US-8674142-B2 | Naphthenic hydrocarbon additives for diaryl phosphide salt formation | PMC ORGANOMETALLIX, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-8674142-B2 | Naphthenic hydrocarbon additives for diaryl phosphide salt formation | PMC ORGANOMETALLIX, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| WO-2012163837-A1 | LIGANDS AND CATALYST SYSTEMS FOR HYDROFORMYLATION PROCESSES | UMICORE AG & CO. KG (DE) | 2012-12-06 | — | — | WO | disclosed |
| US-20100234642-A1 | NAPHTHENIC HYDROCARBON ADDITIVES FOR DIARYL PHOSPHIDE SALT FORMATION | ARKEMA INC. (US) | 2010-09-16 | — | — | US | disclosed |
| US-20100234642-A1 | NAPHTHENIC HYDROCARBON ADDITIVES FOR DIARYL PHOSPHIDE SALT FORMATION | ARKEMA INC. (US) | 2010-09-16 | — | — | US | disclosed |
| EP-2007703-A1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Lucite International UK Limited (GB) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007119079-A1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140114090-A1 | LIGANDS AND CATALYST SYSTEMS FOR HYDROFORMYLATION PROCESSES | ADH5, HRH4, ADH1C | NOS2 4422/4885CNR2 485/4885ALDH1A1 196/4885 |
| US-20100234642-A1 | NAPHTHENIC HYDROCARBON ADDITIVES FOR DIARYL PHOSPHIDE SALT FORMATION | TST, TEC, NPM1 | NOS2 3408/4885CNR2 3165/4885ALDH1A1 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.